UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------------------
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
------------------------------------------
Neose Technologies, Inc.
-----------------------------------------
Name of Issuer
Common Stock, par value $.01 per share
------------------------------------------
(Title of Class of Securities)
640522 10 8
-----------
CUSIP Number
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes to Schedule 13G).
1
<PAGE>
SCHEDULE 13G
CUSIP No. 640522 10 8
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lindsay A. Rosenwald, M.D.
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP (a) [ ] (b) [ ]
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5) SOLE VOTING POWER
473,673 /1/
NUMBER ----------------------------------------------------
OF 6) SHARED VOTING POWER
SHARES 32,000 /2/
BENEFICIALLY ----------------------------------------------------
OWNED BY 7) SOLE DISPOSITIVE POWER
EACH 473,673 /1/
REPORTING ----------------------------------------------------
PERSON 8) SHARED DISPOSITIVE POWER
WITH 32,000 /2/
----------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
505,673 /1/
- --------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES [X]
- --------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.3%
- --------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
- --------
1 Includes non-qualified stock options in the amount of 3,333 shares and
1,423 shares granted to Dr. Rosenwald on 6/19/97 and 1/2/98 respectively.
2 Excludes (i) 75,624 shares of Common Stock owned by Dr. Rosenwald's wife
and (ii) 30,250 shares of Common Stock held by Dr. Rosenwald's wife as
custodian for Dr. Rosenwald's children, as to which Dr. Rosenwald disclaims
beneficial ownership.
2
<PAGE>
Item 1.
(a) Name of Issuer:
Neose Technologies, Inc. (the "Company")
(b) Address of Issuer's Principal Executive Offices:
102 Witmer Road
Horsham, PA 19044
Item 2.
(a) Name of Person Filing:
Lindsay A. Rosenwald, M.D. ("Dr. Rosenwald")
(b) Address of Principal Business Office or, if None, Residence:
787 Seventh Avenue, 48th Floor
New York, N.Y. 10019
(c) Citizen:
Dr. Rosenwald is a citizen of the United States.
(d) Title of Class of Securities:
Common Stock, $0.01 par value ("shares").
(e) CUSIP#:
640522 10 8
Item 3.
Not applicable.
Item 4. Ownership:
For information concerning the ownership of Common Stock of the
Company by Dr. Rosenwald, see Items 5 through 9 and 11 of the
cover
3
<PAGE>
page to this schedule 13G and footnotes thereto.
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported On By the Parent
Holding Company:
Not applicable.
Item 8. Identification and Classification of Members of the Group:
Not applicable.
Item 9. Notice of Dissolution of Group:
Not applicable.
Item 10. Certification:
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 12, 1998
New York, New York
/s/ Lindsay A. Rosenwald, M.D.
------------------------------
Lindsay A. Rosenwald, M.D.
4
